Docetaxel, Gemcitabine, and Filgrastim (G-CSF) or Pegfilgrastim in Treating Patients With Advanced, Persistent, or Recurrent Uterine Leiomyosarcoma

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

December 31, 2003

Primary Completion Date

July 31, 2006

Conditions
Sarcoma
Interventions
BIOLOGICAL

filgrastim

BIOLOGICAL

pegfilgrastim

DRUG

docetaxel

DRUG

gemcitabine hydrochloride

Trial Locations (60)

11203

SUNY Downstate Medical Center, Brooklyn

12208

New York Oncology Hematology, PC at Albany Regional Cancer Care, Albany

19001

Rosenfeld Cancer Center at Abington Memorial Hospital, Abington

19102

Drexel University College of Medicine - Center City Hahnemann Campus, Philadelphia

19713

CCOP - Christiana Care Health Services, Newark

22908

University of Virginia Cancer Center, Charlottesville

27103

Forsyth Regional Cancer Center at Forsyth Medical Center, Winston-Salem

27710

Duke Comprehensive Cancer Center, Durham

28801

Hope A Women's Cancer Center, Asheville

29425

Hollings Cancer Center at Medical University of South Carolina, Charleston

30912

MBCCOP-Medical College of Georgia Cancer Center, Augusta

31208

Medical Center of Central Georgia, Macon

38120

Baptist Centers for Cancer Care, Memphis

44060

Lake/University Ireland Cancer Center, Mentor

44106

Case Comprehensive Cancer Center, Cleveland

44111

Cleveland Clinic Cancer Center at Fairview Hospital, Cleveland

44195

Cleveland Clinic Taussig Cancer Center, Cleveland

45267

Charles M. Barrett Cancer Center at University Hospital, Cincinnati

45409

David L. Rike Cancer Center at Miami Valley Hospital, Dayton

46360

Saint Anthony Memorial Health Centers, Michigan City

52242

Holden Comprehensive Cancer Center at University of Iowa, Iowa City

54601

Gundersen Lutheran Cancer Center at Gundersen Lutheran Medical Center, La Crosse

57105

Avera Cancer Institute, Sioux Falls

57701

Rapid City Regional Hospital, Rapid City

60435

Joliet Oncology-Hematology Associates, Limited - West, Joliet

60507

Rush-Copley Cancer Care Center, Aurora

60521

Hinsdale Hematology Oncology Associates, Hinsdale

60612

Rush University Medical Center, Chicago

61801

Carle Cancer Center at Carle Foundation Hospital, Urbana

CCOP - Carle Cancer Center, Urbana

63110

Siteman Cancer Center at Barnes-Jewish Hospital, St Louis

64131

CCOP - Kansas City, Kansas City

65203

Ellis Fischel Cancer Center at University of Missouri - Columbia, Columbia

65802

CCOP - Cancer Research for the Ozarks, Springfield

65804

St. John's Regional Health Center, Springfield

65807

Hulston Cancer Center at Cox Medical Center South, Springfield

68114

Methodist Cancer Center at Methodist Hospital - Omaha, Omaha

70815

Woman's Hospital, Baton Rouge

73104

Oklahoma University Medical Center, Oklahoma City

74104

Cancer Care Associates - Midtown Tulsa, Tulsa

90027

Kaiser Permanente Medical Center - Los Angeles, Los Angeles

90095-1781

Jonsson Comprehensive Cancer Center at UCLA, Los Angeles

06102-5037

Helen and Harry Gray Cancer Center at Hartford Hospital, Hartford

06050

New Britain General Hospital, New Britain

31403-3089

Curtis & Elizabeth Anderson Cancer Institute at Memorial Health University Medical Center, Savannah

60637-1470

University of Chicago Cancer Research Center, Chicago

21231-2410

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore

39216-4505

University of Mississippi Medical Center, Jackson

08053

Fox Chase Virtua Health Cancer Program - Marlton, Marlton

07103

UMDNJ University Hospital, Newark

08043

Cancer Institute of New Jersey at Cooper - Voorhees, Voorhees Township

Fox Chase Virtua Health Cancer Program at Virtua West Jersey, Voorhees Township

87131-5636

University of New Mexico Cancer Research and Treatment Center, Albuquerque

11794-8174

Stony Brook University Cancer Center, Stony Brook

27599-7295

Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill

27157-1096

Wake Forest University Comprehensive Cancer Center, Winston-Salem

43214-3998

Riverside Methodist Hospital Cancer Care, Columbus

17033-0850

Penn State Cancer Institute at Milton S. Hershey Medical Center, Hershey

19111-2497

Fox Chase Cancer Center, Philadelphia

02905

Women and Infants Hospital of Rhode Island, Providence

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Gynecologic Oncology Group

NETWORK

NCT00101127 - Docetaxel, Gemcitabine, and Filgrastim (G-CSF) or Pegfilgrastim in Treating Patients With Advanced, Persistent, or Recurrent Uterine Leiomyosarcoma | Biotech Hunter | Biotech Hunter